Litcius/Paper detail

Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC

Carol S. Leung, Benoı̂t J. Van den Eynde

2022Cancer Cell11 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationChemotherapyMedicineImmunologyCancer researchInternal medicineCancer Immunotherapy and BiomarkersLymphoma Diagnosis and TreatmentImmunotherapy and Immune Responses
Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC | Litcius